Membrane bionic supramolecular nanomaterials for co-delivered of ribociclib and PEG10 siRNA for targeted therapy in breast cancer

已完结 10 由大湖发布于 2026/9/24 15:28:01

DOI:10.1016/j.canlet.2026.218737
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors, such as ribociclib (RB), limits breast cancer therapy. Although PEG10 siRNA (siPEG10) can counteract this resistance, achieving ta

应助信息

1天前

打酱油

af3117c7b7e911f19e1b208810ba6e4f.pdf 已采纳

1天前

Book学术机器人

2026/9/24 15:28:01 未找到该文献，机器人已退出，请等待人工下载

2026/9/24 15:28:01 Book学术AI机器人收到请求，开始寻找文献

2026/9/24 15:28:01 已向机器人发送请求

1天前

大湖发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyMultiscale Spatial Fusion Feature-Driven Characterization of Gastric Cancer Invasive Margins: A Multicenter Cohort Study for Preoperative Accurate Differentiation Between T4a and T4b Subtypes.